Literature DB >> 27869598

Highly Divergent Dengue Virus Type 2 in Traveler Returning from Borneo to Australia.

Wenjun Liu, Paul Pickering, Sebastián Duchêne, Edward C Holmes, John G Aaskov.   

Abstract

Dengue virus type 2 was isolated from a tourist who returned from Borneo to Australia. Phylogenetic analysis identified this virus as highly divergent and occupying a basal phylogenetic position relative to all known human and sylvatic dengue virus type 2 strains and the most divergent lineage not assigned to a new serotype.

Entities:  

Keywords:  Australia; Borneo; DENV-2; dengue virus; dengue virus type 2; divergence; evolution; phylogeny; sylvatic cycle; traveler; viruses

Mesh:

Substances:

Year:  2016        PMID: 27869598      PMCID: PMC5189156          DOI: 10.3201/eid2212.160813

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Outbreaks of dengue have been reported for several centuries in the Old World and the New World. Dengue is a major cause of illness and death globally, and there are high levels of infection in many tropical and subtropical localities populated by Aedes mosquito vectors. Despite their role in public health, the origin of the 4 serotypes of dengue virus (DENV-1–DENV-4) that are the causative agents of what now is defined as dengue remains unclear. In 1967, Rudnick et al. () combined a fragmentary body of evidence to propose that dengue might have a sylvatic (jungle) cycle similar to that of another flavivirus (yellow fever virus). Isolation of 4 serotypes of DENV from humans in the Asia–Pacific region during 1943–1956 (–) was compatible with the idea that DENV might have originated in this region. Genome sequences of DENV-2 and DENV-4 isolated from sylvatic settings (i.e., from nonhuman primates) occupied basal positions on phylogenetic trees of those serotypes, which suggested that each DENV serotype evolved separately in sylvatic settings before later, independent, cross-species transmission to humans in urban and semiurban settings (,). DENV-2 and DENV-4 have been isolated from nonhuman primates and occupy divergent phylogenetic positions, which suggests that that they are truly sylvatic. In contrast, no sylvatic strains have been identified as DENV-3, and an early sylvatic strain of DENV-1 probably was a spillback from humans to other primates (). However, a highly divergent sequence of DENV-1, which was isolated from a patient who had vacationed in Brunei, was recently reported (). This virus was basal to all other strains of DENV-1 by phylogenetic analyses, which suggests the presence of another sylvatic virus lineage in Southeast Asia, albeit of unknown animal origin. Despite the central role of sylvatic viruses in our understanding of evolution and emergence of human dengue (), to our knowledge, there are no reports of continuous transmission of sylvatic strains of DENV in a truly sylvatic setting. Much of the uncertainty over the nature and role of sylvatic DENV arises because of the small number of such isolates available and the lack of studies of DENV ecology outside a human setting. Thus, although phylogenetic divergence alone is insufficient to definitively prove the existence of sylvatic transmission, it at least shows that a greater diversity of viruses exist than are usually assigned as causing dengue in humans. In this report, we describe a highly divergent strain of DENV-2 isolated from an acute-phase serum specimen from a patient (human ethical approval for this study precludes identification of the patient) in whom dengue developed after the patient returned from a vacation in Borneo to Australia in early 2015.

The Study

The study was approved by the Queensland University of Technology (Brisbane, Queensland, Australia) (Human Research Ethics approval no. 1300000333). DENV-2 was isolated from a serum specimen by cultivation in Aedes albopictus mosquito C6-36 cells. The virus was recognized by pan-flavivirus monoclonal antibodies 6B-6C1 () and 4G2 () and DENV-2–specific monoclonal antibodies 3H5 (), 5H12, and 6B2 () in indirect immunofluorescence assays with infected C6-36 cells. However, it was not recognized by monoclonal antibody 6F3.1, which reacts with a serologic epitope 9RNTPFNMLKRE19 in the capsid protein of nonsylvatic strains of DENV-2. The consensus sequence of the viral genome was obtained by using 3′ and 5′ random amplification of cDNA ends (,) and reverse transcription PCR of ≈1-kb overlapping regions of the genome. Sequences of purified cDNA fragments generated by reverse transcription PCR were determined by using the dye di-deoxy chain termination method at the Australian Genome Research Facility (Brisbane). Phylogenetic analysis of the complete viral genome (10,736 nt) by using maximum-likelihood methods () unambiguously placed this sequence, denoted QML22/2015 (GenBank accession no. KX274130), as a highly divergent member of DENV-2 with a strikingly basal phylogenetic position relative to all human and sylvatic DENV-2 sequences isolated (Figure 1). This lineage is the most divergent new lineage of DENV identified, even greater than that of DENV-1 Brun2014 (), and is located approximately midway between the genetic divergence seen at the level of serotypes and that of genotypes within serotypes.
Figure 1

A) Maximum-likelihood phylogenetic tree of 500 complete genome sequences of DENV-1–DENV-4 (alignment length of 10,185 nt), including QML22/2015, estimated by using the generalized time-reversible invariable sites gamma model of nucleotide substitution in PhyML () and nearest-neighbor interchange plus subtree pruning, and regrafting branch-swapping. The tree is midpoint rooted for clarity, and sequences are color coded according to their putative transmission cycle (human, black; sylvatic, blue); red indicates the highly divergent QML22/2015 lineage isolated in this study. B) Regression of root-to-tip genetic distances of 119 representative human and sylvatic complete genome sequences of DENV-2 (alignment length 10,173 nt) against time (year) of sampling. The input phylogenetic tree was estimated by using the same maximum-likelihood procedure. Three regression lines and slopes are shown; slopes indicate an estimate of the virus nucleotide substitution rate (substitutions/site/year). Blue line indicates rate for entire DENV-2 data set; dashed line indicates rate for sylvatic DENV-2 sequences; black line indicates rate for human DENV-2 sequences. There is a marked difference between sylvatic and human rates. DENV, dengue virus.

A) Maximum-likelihood phylogenetic tree of 500 complete genome sequences of DENV-1–DENV-4 (alignment length of 10,185 nt), including QML22/2015, estimated by using the generalized time-reversible invariable sites gamma model of nucleotide substitution in PhyML () and nearest-neighbor interchange plus subtree pruning, and regrafting branch-swapping. The tree is midpoint rooted for clarity, and sequences are color coded according to their putative transmission cycle (human, black; sylvatic, blue); red indicates the highly divergent QML22/2015 lineage isolated in this study. B) Regression of root-to-tip genetic distances of 119 representative human and sylvatic complete genome sequences of DENV-2 (alignment length 10,173 nt) against time (year) of sampling. The input phylogenetic tree was estimated by using the same maximum-likelihood procedure. Three regression lines and slopes are shown; slopes indicate an estimate of the virus nucleotide substitution rate (substitutions/site/year). Blue line indicates rate for entire DENV-2 data set; dashed line indicates rate for sylvatic DENV-2 sequences; black line indicates rate for human DENV-2 sequences. There is a marked difference between sylvatic and human rates. DENV, dengue virus. Although the nucleotide sequence of the open reading frame of QML22/2015 was strikingly different from those of other strains of DENV-2, sequence and predicted secondary RNA structure of 5′ and 3′ untranslated regions of the QML22/2015 genome were nearly identical with those of other strains of DENV-2, which confirmed the critical role of these elements in virus replication. Sliding-window analysis of genetic distance across the viral genome showed no regions in which QML22/2015 was disproportionately similar to human DENV-2 sequences (Figure 2).
Figure 2

Sliding-window analysis of mean genetic (nucleotide) distance across the dengue virus type 2 (DENV-2) genome. Red line indicates comparison between QML22/2015 and human DENV-2 sequences. Equivalent analyses were performed on sylvatic DENV-2 versus human DENV-2 (blue line) and within the human DENV-2 sequences (black line). This analysis was based on genetic distances calculated by using sliding windows of 200 nt on the DENV-2 data described in Figure 1 and was performed by using the Analysis of Phylogenetics and Evolution Package in R software ().

Sliding-window analysis of mean genetic (nucleotide) distance across the dengue virus type 2 (DENV-2) genome. Red line indicates comparison between QML22/2015 and human DENV-2 sequences. Equivalent analyses were performed on sylvatic DENV-2 versus human DENV-2 (blue line) and within the human DENV-2 sequences (black line). This analysis was based on genetic distances calculated by using sliding windows of 200 nt on the DENV-2 data described in Figure 1 and was performed by using the Analysis of Phylogenetics and Evolution Package in R software ().

Conclusions

Although it is tempting to estimate the time of origin of this novel DENV-2, as performed for other divergent DENV lineages (), we have not made this estimation because our data provided strong evidence for a marked difference in evolutionary rate between human and sylvatic strains of DENV-2, which will confound all attempts at molecular clock dating. Regression analysis of root-to-tip genetic distances against time (year) of sampling suggests that sylvatic strains of DENV-2 are evolving slower than urban (human) strains, most likely because of differences in selection pressure, replication dynamics, or both, and in contrast to previous observations (). The QML22/2015 isolate is closer to the human distribution than the sylvatic distribution of root-to-tip genetic distances, which suggests that this lineage might not have had only sylvatic transmission during its evolutionary history. Further studies are needed to determine whether this virus has infected other humans in Indonesia or other localities and identify genotypic changes that might give this virus distinctive phenotypic properties. The discovery of this and other highly divergent strains of DENV further emphasizes the need for biodiversity surveys of this major group of viruses in animals other than humans. It also suggests that gaps in DENV phylogeny might be filled after wider sampling.
  13 in total

1.  Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand.

Authors:  W M HAMMON; A RUDNICK; G E SATHER
Journal:  Science       Date:  1960-04-15       Impact factor: 47.728

2.  ape 3.0: New tools for distance-based phylogenetics and evolutionary analysis in R.

Authors:  Andrei-Alin Popescu; Katharina T Huber; Emmanuel Paradis
Journal:  Bioinformatics       Date:  2012-04-11       Impact factor: 6.937

3.  Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses.

Authors:  E Wang; H Ni; R Xu; A D Barrett; S J Watowich; D J Gubler; S C Weaver
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Sequence analysis of RNA species synthesized by Q beta replicase without template.

Authors:  C K Biebricher; R Luce
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

5.  Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.

Authors:  Z Jianmin; M L Linn; R Bulich; M K Gentry; J G Aaskov
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Sylvatic dengue viruses share the pathogenic potential of urban/endemic dengue viruses.

Authors:  Nikos Vasilakis; Jane Cardosa; Mawlouth Diallo; Amadou A Sall; Edward C Holmes; Kathryn A Hanley; Scott C Weaver; Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2010-04       Impact factor: 5.103

7.  Possible jungle dengue--recent studies and hypotheses.

Authors:  A Rudnick; N J Marchette; R Garcia
Journal:  Jpn J Med Sci Biol       Date:  1967-12

Review 8.  Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health.

Authors:  Nikos Vasilakis; Jane Cardosa; Kathryn A Hanley; Edward C Holmes; Scott C Weaver
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

9.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Authors:  E A Henchal; M K Gentry; J M McCown; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1982-07       Impact factor: 2.345

10.  Highly divergent dengue virus type 1 genotype sets a new distance record.

Authors:  Alyssa T Pyke; Peter R Moore; Carmel T Taylor; Sonja Hall-Mendelin; Jane N Cameron; Glen R Hewitson; Dennis S Pukallus; Bixing Huang; David Warrilow; Andrew F van den Hurk
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

View more
  17 in total

1.  Lack of Evidence of Sylvatic Transmission of Dengue Viruses in the Amazon Rainforest Near Iquitos, Peru.

Authors:  Michael J Turell; Alfonso S Gozalo; Carolina Guevara; George B Schoeler; Faustino Carbajal; Victor M López-Sifuentes; Douglas M Watts
Journal:  Vector Borne Zoonotic Dis       Date:  2019-04-09       Impact factor: 2.133

2.  Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.

Authors:  Rita E Chen; Brittany K Smith; John M Errico; David N Gordon; Emma S Winkler; Laura A VanBlargan; Chandni Desai; Scott A Handley; Kimberly A Dowd; Emerito Amaro-Carambot; M Jane Cardosa; Carlos A Sariol; Esper G Kallas; Rafick-Pierre Sékaly; Nikos Vasilakis; Daved H Fremont; Stephen S Whitehead; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2021-10-04       Impact factor: 31.316

3.  Discriminating arboviral species.

Authors:  Yiyuan Li; Angela C O'Donnell; Howard Ochman
Journal:  J Gen Virol       Date:  2021-04       Impact factor: 3.891

4.  Shifts in mosquito diversity and abundance along a gradient from oil palm plantations to conterminous forests in Borneo.

Authors:  Katherine I Young; Michaela Buenemann; Nikos Vasilakis; David Perera; Kathryn A Hanley
Journal:  Ecosphere       Date:  2021-04-23       Impact factor: 3.171

Review 5.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

6.  Dengue outbreaks: unpredictable incidence time series.

Authors:  A F B Gabriel; A P Alencar; S G E K Miraglia
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo.

Authors:  Katherine I Young; Stephanie Mundis; Steven G Widen; Thomas G Wood; Robert B Tesh; Jane Cardosa; Nikos Vasilakis; David Perera; Kathryn A Hanley
Journal:  Parasit Vectors       Date:  2017-08-31       Impact factor: 3.876

8.  Complete Genome Sequence of a Highly Divergent Dengue Virus Type 2 Strain, Imported into Australia from Sabah, Malaysia.

Authors:  Alyssa T Pyke; Bixing Huang; David Warrilow; Peter R Moore; Jamie McMahon; Bruce Harrower
Journal:  Genome Announc       Date:  2017-07-20

9.  Identification of Mosquito Bloodmeals Collected in Diverse Habitats in Malaysian Borneo Using COI Barcoding.

Authors:  Katherine I Young; Joseph T Medwid; Sasha R Azar; Robert M Huff; Hannah Drumm; Lark L Coffey; R Jason Pitts; Michaela Buenemann; Nikos Vasilakis; David Perera; Kathryn A Hanley
Journal:  Trop Med Infect Dis       Date:  2020-04-01

10.  Incidence and epidemiological features of dengue in Sabah, Malaysia.

Authors:  Amanda Murphy; Giri Shan Rajahram; Jenarun Jilip; Marilyn Maluda; Timothy William; Wenbiao Hu; Simon Reid; Gregor J Devine; Francesca D Frentiu
Journal:  PLoS Negl Trop Dis       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.